ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2020
Alcohol Consumption, Cigarette Smoking, and Risk of Breast Cancer for
Open access · bronzeAbstract read
In one paragraph
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.
- A Meta-Analysis of Induced Abortion, Alcohol Consumption, and Smoking Triggering Breast Cancer Risk among Women from Developed and Least Developed Countries.International journal of clinical practice · 2022Pooled it
- Article
- Health Behaviors and Cancer Diagnosis Among Individuals with Pathogenic Variants Associated with Hereditary Breast and Ovarian Cancer or Lynch Syndrome.Journal of personalized medicine · 2025Article
- Trend analysis of cancer mortality and years of life lost in the South of Iran 2004-2019. Joinpoint regression analysis.BMC cancer · 2025Article
- Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriers.NPJ breast cancer · 2025Article
- Article
- Comprehensive Analysis of Predictors and Outcomes in Breast Cancer Screening in Romania: Insights from Demographic, Clinical, and Lifestyle Factors.Journal of clinical medicine · 2025Article
- Exploring the molecular mechanisms network of breast cancer by multi-omics analysis.Asia-Pacific journal of clinical oncology · 2025Article
- Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies.Alcohol, clinical & experimental research · 2024Review
- Validation of the BOADICEA model in a prospective cohort ofJournal of medical genetics · 2024Article
- Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.JAMA network open · 2024Article
- Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS).Cancers · 2024Article
- Computational prognostic evaluation of Alzheimer's drugs from FDA-approved database through structural conformational dynamics and drug repositioning approaches.Scientific reports · 2023Article
- Review
- Predicting Quality of Life in Women with Breast Cancer Who Engage in Physical Exercise: The Role of Psychological Variables.Healthcare (Basel, Switzerland) · 2023Article
- Brca1Cancer science · 2022Article
- Field cancerization in breast cancer.The Journal of pathology · 2022Review
- The importance of addressing early life environmental exposures in cancer epidemiology.Current epidemiology reports · 2022Article
- Association between germline pathogenic variants and breast cancer risk in Japanese women: The HERPACC study.Cancer science · 2022Article
- Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid.International journal of molecular sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
59 authors at 20 institutions in 15 countries.
Hongyan LiHuntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.ORCID 0000-0002-8166-9448
Mary Beth TerryDepartment of Epidemiology, Columbia University, New York, New York.
Antonis C AntoniouCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9223-3116
Kelly-Anne PhillipsCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.ORCID 0000-0002-0475-1771
Karin KastDepartment of Gynecology and Obstetrics, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität, Dresden, Germany.
Thea M MooijDepartment of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Christoph EngelInstitute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Germany.ORCID 0000-0002-7247-282X
Catherine NoguèsInstitut Paoli-Calmettes, Département d'Anticipation et de Suivi des Cancers, Oncogénétique Clinique and Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France.
Dominique Stoppa-LyonnetInstitut Curie, Service de Génétique Médicale, Paris, France.ORCID 0000-0002-5438-8309
Christine LassetUnité de prévention et Epidémiologie Génétique, Centre Léon Bérard - Lyon/UMR CNRS 5558, Université de Lyon - Lyon, France.
Pascaline BerthetDépartement de biopathologie, Oncogénétique clinique, Centre François Baclesse - Caen, France.
Veronique MariCLCC Antoine Lacassagne, Département d'Hématologie - Oncologie médicale, Nice, France.
Olivier CaronDépartement de Médecine, Gustave Roussy Hôpital Universitaire - Villejuif, France.ORCID 0000-0001-8934-2071
GENEPSO study
Daniel BarrowdaleCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
Debra FrostCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
Carole BrewerDepartment of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
D Gareth EvansGenomic Medicine, NIHR Manchester Biomedical Research Centre, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.ORCID 0000-0002-8482-5784
Louise IzattClinical Genetics, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.
Lucy SideWessex Clinical Genetics Service, The Princess Anne Hospital, Southampton, United Kingdom.
Lisa WalkerOxford Regional Genetics Service, Churchill Hospital, Oxford, United Kingdom.
Marc TischkowitzUniversity of Cambridge Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Center, Cambridge Biomedical Campus, Cambridge, United Kingdom.
Mark T RogersAll Wales Medical Genetics Services, University Hospital of Wales, Cardiff, United Kingdom.
Mary E PorteousSouth East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
Katie SnapeMedical Genetics Unit, St. George's, University of London, London, United Kingdom.
EMBRACE study
Hanne E J Meijers-HeijboerDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
Johan J P GilleDepartment of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.ORCID 0000-0003-4526-298X
Marinus J BlokDepartment of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
Nicoline HoogerbruggeDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.ORCID 0000-0003-2393-8141
HEBON Investigators
Mary B DalyDepartment of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
Irene L AndrulisDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Saundra S BuysDepartment of Medicine, University of Utah Health Sciences Center, Huntsman Cancer Institute, Salt Lake City, Utah.
Esther M JohnStanford University School of Medicine, Department of Medicine, Division of Oncology, and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.ORCID 0000-0003-3259-8003
Sue-Anne McLachlanDepartment of Medicine, St. Vincent's Hospital, The University of Melbourne, Parkville, Victoria, Australia.
Michael FriedlanderDepartment of Medical Oncology, Prince of Wales Hospital, Randwick, New South Wales, Australia.ORCID 0000-0003-3090-795X
kConFab Investigators
Yen Y TanDepartment of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Ana OsorioHuman Genetics Group, Spanish National Cancer Centre (CNIO) and Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
Trinidad CaldesMolecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.ORCID 0000-0002-1038-5392
Anna JakubowskaDepartment of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
Jacques SimardGenomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, Quebec City, Quebec, Canada.
Christian F SingerDepartment of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Edith OlahDepartment of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
Marie NavratilovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, Czech Republic.
Lenka ForetovaDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, Czech Republic.
Anne-Marie GerdesThe Department of Oncology and Pathology, Karolinska Institute, Stockholm, Sweden.
Marie-José Roos-BlomDepartment of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Brita ArverDepartment of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Håkan OlssonDepartment of Oncology, Lund University Hospital, Lund, Sweden.
Rita K SchmutzlerCenter for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany.
John L HopperCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.
Roger L MilneCentre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Victoria, Australia.ORCID 0000-0001-5764-7268
Douglas F EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, United Kingdom.
Flora E Van LeeuwenDepartment of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Matti A RookusDepartment of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nadine Andrieu *INSERM, U900, Paris, France. david.goldgar@hsc.utah.edu nadine.andrieu@curie.fr.
David E Goldgar *Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah. david.goldgar@hsc.utah.edu nadine.andrieu@curie.fr.
Dutch Cancer Society · NLThe University of Melbourne · AULund University · SEMRC Epidemiology Unit · GBChurchill Hospital · GBComprehensive Cancer Center Vienna · ATFox Chase Cancer Center · USGuy's and St Thomas' NHS Foundation Trust · GBHuntsman Cancer Institute · USINSEAD · FRPeter MacCallum Cancer Centre · AURadboud University Nijmegen · NLSt George's, University of London · GBUniversity of Cologne · DEUniversity of Utah · USAmsterdam UMC Location Vrije Universiteit Amsterdam · NLCentre Antoine Lacassagne · FRCentre François Baclesse · LUCentre hospitalier universitaire de Québec · CAColumbia University Irving Medical Center · US
Funding
Breast Cancer Family Registry CohortUM1CA164920 · NCI · CANCER PREVENTION INSTIT OF CALIFORNIA · PI ANDRULIS, IRENE, BUYS, SAUNDRA S · 2012 to 2017
$12.7MGenes, environment and breast cancer risk: The 15 year follow-up of the Prof-SC (Diversity Supplement)R01CA159868 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOPPER, JOHN L, TERRY, MARY BETH · 2011 to 2015
$9.0MCancer Research UK 10118Cancer Research UK 20861Cancer Research UK 23382Cancer Research UK A10118Cancer Research UK A11174Cancer Research UK A11990Cancer Research UK A20861Cancer Research UK C12292/A11174Cancer Research UK C12292/A20861Cancer Research UK C1287/A11990NCI NIH HHS R01 CA159868NCI NIH HHS UM1 CA164920
Abstract
backgroundTobacco smoking and alcohol consumption have been intensively studied in the general population to assess their effects on the risk of breast cancer, but very few studies have examined these effects in
methodsUsing a large international pooled cohort of
resultsFor both
conclusionsThe finding that smoking during the prereproductive years increases breast cancer risk for mutation carriers warrants further investigation. IMPACT: This is the largest prospective study of
Indexed as
Life StyleAdultAlcohol DrinkingBRCA1 ProteinBRCA2 ProteinBreast NeoplasmsCigarette SmokingFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMiddle AgedMutationProspective StudiesReproductive HistoryRetrospective StudiesBRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, human
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.